Cancer Research Career Enhancement and Related Activities

癌症研究职业提升及相关活动

基本信息

项目摘要

PROJECT SUMMARY: CANCER RESEARCH CAREER ENHANCEMENT As the only academic Cancer Center in its four-county catchment area (South Florida), the Sylvester Comprehensive Cancer Center (Sylvester) has a unique responsibility to provide cancer-focused education and training across the career continuum. Sylvester’s Office of Education and Training (OET) coordinates these activities, ensuring they meet and exceed the needs of diverse learners, including students, pre- and postdoctoral trainees, faculty, and healthcare professionals. Kerry L. Burnstein, PhD, Associate Director for Education and Training leads the OET, overseeing the strategic development, coordination, and evaluation of these efforts with assistance from Sylvester leadership and administration, Sylvester’s External Advisory Board, and the Cancer Education Leadership Council, an internal advisory committee comprising University leaders in education, training, and mentoring. They work together to achieve the career enhancement priorities identified in Sylvester’s 2014-2018 Strategic Plan to 1) Build and sustain cancer research careers through stage-specific scientific and professional development; and 2) Provide broad, crosscutting career enhancement and educational programs that facilitate collaborative, interdisciplinary cancer research. While many of the Center’s education and training activities are new, for the past 12 years the Cancer Biology Graduate (CAB) Program has successfully educated dozens of promising graduate students in basic or translational cancer research. Sylvester trainees have been productive and engaged in impactful cancer research; of the 150 publications highlighted by Sylvester’s three Research Programs, trainees were first or second author on 50%. Recently, Sylvester members received five cancer-focused or related T32 training grants, an international U54 grant with Argentina that has a significant education and training component, and an NCI K12 Calabresi award, which will begin enrolling physician scientists in 2019. To extend the impact of these grants, Sylvester will fund an additional trainee for the T32s awards and the K12. Sylvester supports traditional career enhancement activities such as distinguished lecture series, annual retreats, trainee speaking opportunities, and novel educational strategies including a nurse practitioner oncology fellowship and opportunities for medical students to work in medically underserved communities with cancer control experts. Given the unparalleled multicultural and linguistic diversity of the catchment area, Burnstein and the OET work with the University of Miami Clinical and Translational Science Institute leadership and Sylvester’s Associate Director for Population Science and Cancer Disparity to ensure that trainees receive didactic and experiential instruction on how cancer risk and outcome vary across populations, allowing them to consider and possibly incorporate this knowledge into their research design. Together these efforts foster a pipeline of highly motivated healthcare professionals and researchers, uniquely trained to solve the complex cancer-related problems in their communities and beyond.
项目摘要:癌症研究职业提升 作为其四个县辖区(南佛罗里达州)唯一的学术癌症中心,西尔维斯特 综合癌症中心(西尔维斯特)肩负着提供以癌症为中心的教育的独特责任 西尔维斯特教育和培训办公室 (OET) 负责协调整个职业生涯的培训和培训。 这些活动,确保它们满足并超越不同学习者的需求,包括学生、学前班和 博士后实习生、教师和医疗保健专业人员 Kerry L. Burnstein 博士,副主任。 教育和培训领导 OET,监督战略发展、协调和评估 这些努力得到了西尔维斯特领导和管理、西尔维斯特外部咨询的协助 董事会和癌症教育领导委员会,这是一个由大学组成的内部咨询委员会 他们共同努力实现职业发展的优先事项。 Sylvester 的 2014-2018 年战略计划中确定了 1) 通过以下方式建立和维持癌症研究事业 针对特定阶段的科学和专业发展;以及 2) 提供广泛的、跨领域的职业提升; 和促进协作、跨学科癌症研究的教育计划。 中心的教育和培训活动是新的,过去12年癌症生物学研究生(CAB) 该计划已成功培养了数十名有前途的基础癌症或转化癌症研究生 西尔维斯特学员在 150 名癌症研究中卓有成效并从事有影响力的研究; 在西尔维斯特的三个研究计划重点发表的出版物中,受训者中有 50% 是第一或第二作者。 最近,Sylvester 成员获得了五项以癌症为重点或相关的 T32 培训补助金,一项国际 U54 与阿根廷合作的赠款,其中包含重要的教育和培训内容,以及 NCI K12 Calabresi 奖, 将于 2019 年开始招募医师科学家。为了扩大这些资助的影响,西尔维斯特将资助 T32s 奖项和 K12 的额外实习生支持传统的职业提升。 活动,例如杰出讲座系列、年度静修、实习生演讲机会和小说 教育策略,包括执业护士肿瘤学奖学金和医学生机会 鉴于无与伦比的多元文化,与癌症控制专家一起在医疗服务不足的社区工作。 以及学区的语言多样性,Burnstein 和 OET 与迈阿密大学临床学院合作 和转化科学研究所的领导和西尔维斯特人口科学副主任 癌症差异确保学员接受有关癌症风险和癌症风险的教育和体验指导 结果因人群而异,使他们能够考虑并可能将这些知识纳入他们的 这些共同促进了一批积极主动的医疗保健专业人员和研究设计。 研究人员接受过独特的培训,能够解决社区内外复杂的癌症相关问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kerry L Burnstein其他文献

Kerry L Burnstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kerry L Burnstein', 18)}}的其他基金

Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10814125
  • 财政年份:
    2021
  • 资助金额:
    $ 5.28万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10153099
  • 财政年份:
    2021
  • 资助金额:
    $ 5.28万
  • 项目类别:
Covid-19: Fast-tracking treatment by exploiting the steroid hormone receptor/TMPRSS2 axis
Covid-19:利用类固醇激素受体/TMPRSS2 轴进行快速治疗
  • 批准号:
    10341159
  • 财政年份:
    2021
  • 资助金额:
    $ 5.28万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10190856
  • 财政年份:
    2019
  • 资助金额:
    $ 5.28万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    9789581
  • 财政年份:
    2019
  • 资助金额:
    $ 5.28万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10443633
  • 财政年份:
    2019
  • 资助金额:
    $ 5.28万
  • 项目类别:
A Novel Drug Target for Aggressive Prostate Cancer
侵袭性前列腺癌的新药物靶点
  • 批准号:
    10083680
  • 财政年份:
    2018
  • 资助金额:
    $ 5.28万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8257572
  • 财政年份:
    2009
  • 资助金额:
    $ 5.28万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8257572
  • 财政年份:
    2009
  • 资助金额:
    $ 5.28万
  • 项目类别:
Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.
Vav3 致癌基因对前列腺癌中雄激素受体信号传导的增强作用。
  • 批准号:
    8056479
  • 财政年份:
    2009
  • 资助金额:
    $ 5.28万
  • 项目类别:

相似海外基金

Understanding Ancestral Contribution to Lung Adenocarcinoma
了解祖先对肺腺癌的贡献
  • 批准号:
    10667660
  • 财政年份:
    2022
  • 资助金额:
    $ 5.28万
  • 项目类别:
Understanding Ancestral Contribution to Lung Adenocarcinoma
了解祖先对肺腺癌的贡献
  • 批准号:
    10615251
  • 财政年份:
    2022
  • 资助金额:
    $ 5.28万
  • 项目类别:
Understanding Ancestral Contribution to Lung Adenocarcinoma
了解祖先对肺腺癌的贡献
  • 批准号:
    10190280
  • 财政年份:
    2021
  • 资助金额:
    $ 5.28万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    10190856
  • 财政年份:
    2019
  • 资助金额:
    $ 5.28万
  • 项目类别:
Cancer Research Career Enhancement and Related Activities
癌症研究职业提升及相关活动
  • 批准号:
    9789581
  • 财政年份:
    2019
  • 资助金额:
    $ 5.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了